Role of Survivin in Development of Megakaryocytes and Erythroid Cells

生存素在巨核细胞和红系细胞发育中的作用

基本信息

  • 批准号:
    7921091
  • 负责人:
  • 金额:
    $ 9.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-21 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Although erythroid cells and megakaryocytes derive from a common progenitor and share many essential transcription factors, their terminal maturation follows very different paths: erythroid cells undergo cell cycle exit and enucleation while megakaryocytes continue to progress through the cell cycle, but skip late stages of mitosis to become polyploid cells. In our efforts to identify genes that participate in this process, we discovered that survivin, a member of the inhibitor of apoptosis (IAP) family that also plays an essential role in cytokinesis, is differentially expressed during erythroid versus megakaryocyte development. Erythroid cells express survivin throughout their maturation, up through the terminal orthochromatic stage of differentiation. In contrast, purified murine megakaryocytes express nearly 4-fold lower levels of survivin mRNA compared to erythroid cells and no detectable protein. To investigate whether survivin is involved in the differentiation and/or survival of hematopoietic progenitors, we infected primary mouse bone marrow cells with retroviruses harboring the human survivin cDNA or control retrovirus, and then induced erythroid and megakaryocyte differentiation in both liquid culture and colony-forming assays. These studies revealed that overexpression of survivin antagonized megakaryocyte development, but did not affect the terminal differentiation of red blood cells. In contrast, a 50% reduction in survivin mRNA, caused by a heterozygous loss of survivin, blocked erythroid, but not megakaryocyte, development in vitro. Thus, our preliminary data support a physiologic role for persistent survivin expression in erythroid cells and a significantly reduced level of expression in megakaryocytes. Based on these findings, we hypothesize that persistent survivin expression is required for differentiation and/or survival of erythroid cells, while its reduction is essential for terminal maturation of megakaryocytes. In this application, we propose to investigate how survivin contributes to erythroid cell and megakaryocyte development. Specifically, we plan to 1) Determine the requirement for survivin in red cell and megakaryocyte development by conditional gene targeting in mice, 2) Characterize the mechanism by which survivin participates in erythroid cell differentiation by analyzing the phenotype of cultured erythroid cells with reduced survivin expression and by identifying survivin protein complexes in erythroid cells, and 3) Investigate why persistent survivin expression is inhibitory to megakaryocyte polyploidization and maturation by analysis of transgenic mice that ectopically express survivin in megakaryocytes and erythroid cells. A more detailed assessment of how survivin contributes to hematopoiesis will aid in our understanding of the role of cell cycle regulation and apoptosis in normal blood cell development, and may shed light into the mechanism by which erythroid cells and megakaryocytes arise from a common precursor.
描述(由申请人提供):尽管红系细胞和巨核细胞源自共同的祖细胞并共享许多必需的转录因子,但它们的终末成熟遵循非常不同的路径:红系细胞经历细胞周期退出和去核,而巨核细胞继续通过细胞周期进展,但跳过有丝分裂的晚期阶段成为多倍体细胞。在我们的努力,以确定参与这一过程的基因,我们发现,生存素,细胞凋亡抑制剂(IAP)家族的成员,也发挥了重要作用,在胞质分裂,红细胞与巨核细胞发育过程中的差异表达。红系细胞在其整个成熟过程中表达生存素,直至分化的终末正染阶段。与此相反,纯化的小鼠巨核细胞表达的生存素mRNA水平比红系细胞低近4倍,并且没有检测到蛋白质。为了研究生存素是否参与造血祖细胞的分化和/或存活,我们用携带人生存素cDNA的逆转录病毒或对照逆转录病毒感染原代小鼠骨髓细胞,然后在液体培养和集落形成测定中诱导红系和巨核细胞分化。这些研究表明,生存素的过度表达拮抗巨核细胞的发展,但不影响终末分化的红细胞。与此相反,生存素mRNA的50%的减少,所造成的一个杂合子的生存素的损失,阻止红细胞,但不是巨核细胞,在体外的发展。因此,我们的初步数据支持持续生存素在红系细胞中的表达和巨核细胞中的表达水平显着降低的生理作用。基于这些发现,我们假设,持续生存素的表达是需要分化和/或红系细胞的生存,而其减少是必不可少的巨核细胞的终末成熟。在这个应用中,我们建议调查如何生存素有助于红系细胞和巨核细胞的发育。具体而言,我们计划1)通过小鼠中的条件基因靶向来确定红细胞和巨核细胞发育中对存活素的需求,2)通过分析具有降低的存活素表达的培养红系细胞的表型和通过鉴定红系细胞中的存活素蛋白复合物来表征存活素参与红系细胞分化的机制,3)通过分析在巨核细胞和红系细胞中异位表达生存素的转基因小鼠,研究生存素持续表达抑制巨核细胞多倍化和成熟的原因。生存素如何有助于造血的更详细的评估将有助于我们了解细胞周期调控和细胞凋亡在正常血细胞发育中的作用,并可能揭示红系细胞和巨核细胞从共同的前体细胞产生的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John D Crispino其他文献

John D Crispino的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John D Crispino', 18)}}的其他基金

Identifying the pathways that drive progression of the MPNs to AML
确定推动 MPN 进展为 AML 的途径
  • 批准号:
    10307030
  • 财政年份:
    2021
  • 资助金额:
    $ 9.95万
  • 项目类别:
Identifying the mechanisms of leukemia progression
确定白血病进展的机制
  • 批准号:
    10677759
  • 财政年份:
    2021
  • 资助金额:
    $ 9.95万
  • 项目类别:
Aberrant megakaryopoiesis in the myleoproliferative neoplasms
骨髓增生性肿瘤中异常的巨核细胞生成
  • 批准号:
    10307918
  • 财政年份:
    2021
  • 资助金额:
    $ 9.95万
  • 项目类别:
Identifying the mechanisms of leukemia progression
确定白血病进展的机制
  • 批准号:
    10298553
  • 财政年份:
    2021
  • 资助金额:
    $ 9.95万
  • 项目类别:
Mechanisms of leukemogenesis in Down syndrome
唐氏综合症的白血病发生机制
  • 批准号:
    10307029
  • 财政年份:
    2021
  • 资助金额:
    $ 9.95万
  • 项目类别:
Mechanisms of Leukemogenesis in Down Syndrome
唐氏综合症的白血病发生机制
  • 批准号:
    9913474
  • 财政年份:
    2018
  • 资助金额:
    $ 9.95万
  • 项目类别:
GATA1 Mutation in Defective Erythropoiesis
红细胞生成缺陷中的 GATA1 突变
  • 批准号:
    8651635
  • 财政年份:
    2013
  • 资助金额:
    $ 9.95万
  • 项目类别:
Aberrant Megakaryopoiesis in the Myeloproliferative Neoplasms
骨髓增生性肿瘤中异常的巨核细胞生成
  • 批准号:
    8707548
  • 财政年份:
    2013
  • 资助金额:
    $ 9.95万
  • 项目类别:
GATA1 Mutation in Defective Erythropoiesis
红细胞生成缺陷中的 GATA1 突变
  • 批准号:
    9115144
  • 财政年份:
    2013
  • 资助金额:
    $ 9.95万
  • 项目类别:
GATA1 Mutation in Defective Erythropoiesis
红细胞生成缺陷中的 GATA1 突变
  • 批准号:
    8737256
  • 财政年份:
    2013
  • 资助金额:
    $ 9.95万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 9.95万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 9.95万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 9.95万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 9.95万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 9.95万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 9.95万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 9.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 9.95万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 9.95万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 9.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了